Zynerba Pharmaceuticals Inc ZYNE 7.24% investors may have reason for cautious optimism after the company’s recent Fragile X Syndrome treatment data. On Monday, Cantor Fitzgerald analyst Elemer Piros upgraded Zynerba to Overweight and said there is a reasonable change ZYN002 will find commercial success as a treatment for Fragile X.
According to Piros, Cantor Fitzgerald sees a 30 percent probability of ZYN002 making it to the Fragile X market (see his track record here). However, even with less than a one in three chance of success, the Fragile X data has created some major value potential in Zynerba stock.
“Based on the positive Phase 2 FXS results, we are encouraged by the potential for ZYN002 to treat the disease and have assessed the risk-adjusted opportunity for the drug,” Elemer said.
“With an annual price assumption of $45,000 (U.S.) and $32,000 (EU), ZYN002 could reach combined peak sales of $1.5 billion, in our calculation.”
For now, the firm is waiting for additional data and information from the company related to potential fundraising. Elemer expects Zynerba will secure additional financing within the next one to two years and will begin a phase II/III study in early 2018. Cantor Fitzgerald estimates Zynerba will finish 2018 with roughly $73 million in cash on its balance sheet.
Elemer said ZYN002’s potential Fragile X indication adds roughly $13 per share of risk-adjusted value to Zyberba. Cantor Fitzgerald has raised…
Click here to continue reading
Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!
